CLINICAL_TRIALS
research
· 2025-05-14
Clinical Trial Update: Bosentan in the Treatment of Giant Cell Arteritis [Phase 2]
Summary
A Phase 2 clinical trial is evaluating bosentan for Giant Cell Arteritis; the study status is not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Giant Cell Arteritis (GCA) | Phase 2 | Status: NOT_YET_RECRUITING